Inify Laboratories AB — Director's Dealing 2025

Jan 24, 2025

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Monsun AS
2	Reason for the notification
a)	Position/status	A company closely associated with Magne Jordanger, member of the board of directors of Inify Laboratories AB (publ)
b)	Initial Notification / Amendment	Initial
3	Details of the issuer
a)	Name	Inifiy Laboratories AB (publ)
b)	LEI	549300306YYJ3BX3VB98
4	Details of the transaction:
a)	Description of the financial instrument, type of instrument Identification code	Shares in Inify Laboratories AB (publ), with ISIN SE0017486103
b)	Nature of the transaction	Allocation of new shares in subsequent offering
c)	Price(s) and
	volume(s)	Price	Volume(s)
		NOK 4.5	2,034,376
d)	Aggregated
	information — Aggregated volume — Price	Price	Volume(s)
		NOK 4.5	2,034,376
e)	Date of the transaction	2025-01-23
f)	Place of the transaction	Outside a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Fredrik Palm
2	Reason for the notification
a)	Position/status	Chief Executive Officer of Inify Laboratories AB (publ)
b)	Initial Notification / Amendment	Initial
3	Details of the issuer
a)	Name	Inifiy Laboratories AB (publ)
b)	LEI	549300306YYJ3BX3VB98
4	Details of the transaction:
a)	Description of the financial instrument, type of instrument Identification code	Shares in Inify Laboratories AB (publ), with ISIN SE0017486103
b)	Nature of the transaction	Allocation of new shares in subsequent offering
c)	Price(s) and
	volume(s)	Price	Volume(s)
		NOK 4.5	37,979
d)	Aggregated
	information — Aggregated volume	Price	Volume(s)
		NOK 4.5	37,979
	— Price
e)	Date of the transaction	2025-01-23
f)	Place of the transaction	Outside a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Martin Ingvar
2	Reason for the notification
a)	Position/status	Member of the board of directors of Inify Laboratories AB (publ)
b)	Initial Notification / Amendment	Initial
3	Details of the issuer
a)	Name	Inifiy Laboratories AB (publ)
b)	LEI	549300306YYJ3BX3VB98
4	Details of the transaction:
a)	Description of the financial instrument, type of instrument Identification code	Shares in Inify Laboratories AB (publ), with ISIN SE0017486103
b)	Nature of the transaction	Allocation of new shares in subsequent offering
c)	Price(s) and
	volume(s)	Price	Volume(s)
		NOK 4.5	75,363
d)	Aggregated
	information — Aggregated volume — Price	Price	Volume(s)
		NOK 4.5	75,363
e)	Date of the transaction	2025-01-23
f)	Place of the transaction	Outside a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Ann-Charlotte Linderoth
2	Reason for the notification
a)	Position/status	Chief Financial Officer of Inify Laboratories AB (publ)
b)	Initial Notification / Amendment	Initial
3	Details of the issuer
a)	Name	Inifiy Laboratories AB (publ)
b)	LEI	549300306YYJ3BX3VB98
4	Details of the transaction:
a)	Description of the financial instrument, type of instrument Identification code	Shares in Inify Laboratories AB (publ), with ISIN SE0017486103
b)	Nature of the transaction	Allocation of new shares in subsequent offering
c)	Price(s) and
	volume(s)	Price	Volume(s)
		NOK 4.5	22,260
d)	Aggregated
	information — Aggregated	Price	Volume(s)
		NOK 4.5	22,260
	volume — Price
e)	Date of the transaction	2025-01-23
f)	Place of the transaction	Outside a trading venue